Lobbying

American Society for Clinical Pathology's latest lobbying report covers Q2 2026, at $46K. The four quarters Q4 2025–Q3 2026 total $138K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Labor Issues/Antitrust/Workplace.

American Society for Clinical Pathology

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$138K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

American Society for Clinical Pathology lobbying by quarter
American Society for Clinical Pathology lobbying by quarter
QuarterAmountReports
Q4 2022$37K1
Q1 2023$37K1
Q2 2023$40K1
Q3 2023$42K1
Q4 2023$42K1
Q1 2024$42K1
Q2 2024$43K1
Q3 2024$43K1
Q4 2024$43K1
Q1 2025$43K1
Q2 2025$45K1
Q3 2025$46K1
Q4 2025$46K1
Q1 2026$46K1
Q2 2026$46K1
Q3 2026$00

By issue

  • Health issues$160.3K · 15 reports
  • Labor, antitrust and workplace$160.3K · 15 reports
  • Medical research and clinical labs$160.3K · 15 reports
  • Medicare and Medicaid$160.3K · 15 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Bureau of Labor Statistics (BLS)15 reports
  • Centers For Disease Control & Prevention (CDC)15 reports
  • Centers For Medicare and Medicaid Services (CMS)15 reports
  • Food & Drug Administration (FDA)15 reports
  • Health & Human Services, Dept of (HHS)15 reports
  • Health Resources & Services Administration (HRSA)15 reports
  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports
  • Education, Dept of10 reports
  • Veterans Affairs, Dept of (VA)9 reports
  • Bureau of Citizenship & Immigration Services (BCIS)4 reports
  • Homeland Security, Dept of (DHS)4 reports
  • Employment & Training Administration2 reports

Firms it paid

Firm
In-houseAmerican Society for Clinical Pathology$641K15 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/13for Q2In-house$46K
04/13for Q1In-house$46K
02/11for Q4 2025In-house$46K
25/11/07for Q3 2025In-house$46K
25/07/23for Q2 2025In-house$45K
25/07/23for Q2 2025In-house$45K
25/05/06for Q1 2025In-house$43K
25/02/04for Q4 2024In-house$43K
24/10/21for Q3 2024In-house$43K
24/08/06for Q2 2024In-house$43K
24/05/02for Q1 2024In-house$42K
24/01/30for Q4 2023In-house$42K
23/11/14for Q3 2023In-house$42K
23/07/24for Q2 2023In-house$40K
23/04/28for Q1 2023In-house$37K
23/01/09for Q4 2022In-house$37K